1. Abstract
More in vitro studies recently demonstrated a bactericidal and virucidal role for some of the over-the-counter mouthwash solutions. Meanwhile, Game theory and Evolutionary Biology suggests that inhibiting cooperation -reciprocal altruism-between two organisms can negatively affect their survival. Based on a set of relevant publications, it is proposed here that 2019-nCoV may be relying on a “complicit”; be it a particular organism (e.g., bacterial species) or a state of dysbiosis in general. On this premise, the regular use of potent disinfectant (Hydrogen peroxide 2% and chlorhexidine gluconate mixed solution) for oral rinsing and gargling three times daily, through the repeated reduction in microbial load, was tested to determine whether it can induce a strain sufficient to inhibit reciprocal altruism, and hence halt the progression of the disease.
The outcome tested in terms of the change COVID19 PCR and its average Cycle threshold (CT) value for nasopharyngeal-oropharyngeal swabs from the baseline (at diagnosis), changes in the clinical category (improvement Vs. deterioration), and the final disposition (discharge Vs. Death) in different disease categories.
Our findings showed, upon the regular use of mouthwash, more symptoms improvement after two days of treatment, a higher conversion rate to “COVID19-negative PCR” by five days of treatment, and less intubation and mortality, with all P-value < 0.05.
There was also a trend of improvement in other outcome variables, though with no significant statistical difference; namely “shorter hospital stay,” “less progression in Oxygen requirements,” “less rate of plasma transfusion,” and “extent of improvement” in terms of disposition relative to the clinical category on admission.
These findings can be justified by the complicit hypothesis, predicting a rather preventive than a therapeutic advantage for the regular use of potent mouthwash as an additional control measure at the community level.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
ISRCTN10197987 https://doi.org/10.1186/ISRCTN10197987
Funding Statement
The study is funded by Hamad Medical Corporation's Medical Research Center
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Hamad Medical Corporation - Medical Research Center- IRB
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
kmukhter{at}hamad.qa, sq1513914{at}student.qu.edu.qa, mdanjuma{at}hamad.qa, mmohamedali{at}hamad.qa, halfarhan1{at}hamad.qa, mkhudhair{at}hamad.qa, aeltayeh{at}hamad.qa, maldosari1{at}hamad.qa, mbabiker{at}hamad.qa, malmaslamani{at}hamad.qa, rmohamed31{at}hamad.qa, ahassib1{at}hamad.qa, welhadary{at}hamad.qa, mabdulkrim{at}hamad.qa, rsingh{at}hamad.qa
Data Availability
The manuscript is to be shared only with a publishing journal, after signing a Data sharing agreement
2. Abbreviations and Acronyms
- RTI
- Respiratory Tract Infection
- COVID19
- novel Coronavirus disease 2019
- 2019-nCOV
- the novel coronavirus that causes severe acute respiratory illness/ Syndrome
- RT-PCR
- Reverse transcription Polymerase Chain reaction
- CT
- Cycle threshold value; the number of amplification cycles required to reach a fixed (fluorescent) signal to cross the threshold (i.e., exceeds background level).
- RNA
- Ribonucleic acid
- VAP
- Ventilator□associated pneumonia, defined as pneumonia developing in people who have received mechanical ventilation for at least 48 hours.
